Related Experiment Videos
Neuroleptic malignant syndrome in advanced Parkinson's disease
1Department of Neurology, Columbia-Presbyterian Medical Center, New York, New York, USA.
Movement Disorders : Official Journal of the Movement Disorder Society
|December 18, 2001
Abstract:
Neuroleptic malignant syndrome is a serious complication of levodopa withdrawal in patients with Parkinson's disease. We report a patient with advanced parkinsonism who developed neuroleptic malignant syndrome in the setting of inadequate levodopa intake. His symptoms improved with levodopa replacement, but dramatically worsened when enteral feeding was begun due to interference with intestinal absorption of levodopa.